Albany, US, 2019-Sep-05 — /EPR Network/ —Dual antiplatelet therapy is defined as the use of aspirin and P2Y12 receptor inhibitor to prevent blood clotting, and [read full press release…]
Albany, US, 2019-Aug-23 — /EPR Network/ —Long-term graft survival in renal transplantation tends to be influenced by several risk factors, including acute rejection, donor origin [read full press release…]
Although the dual antiplatelet therapy reduces the risks of thromboembolic conditions, it is also associated with a major risk of bleeding that can sometimes be [read full press release…]
Albany, US, 2019-Jul-02 — /EPR Network/ —The market for sirolimus is witnessing an upward surge owing to various reasons ranging right from increase in the [read full press release…]
Albany, US, 2019-Apr-17 — /EPR Network/ —The following research report is a compilation of high-end data that has been researched thoroughly to highlight the various [read full press release…]
Platelets are small blood particles that clump together to form clots. Sometimes, these clots may lead to myocardial infarction or a sudden blockage in the [read full press release…]
